HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Kennedy Selected Research

Neoplasms (Cancer)

1/2021Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: assessing the impact on dose modulation and normal tissue effects when using patient-specific cancer biology.
10/2009Application of Ultrasound for Targeted Nanotherapy of Malignant Tumors.
12/2006Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts.
12/2001Potential clinical utility of CA-125 in responsive but persistent large-volume ovarian cancer following platinum-based chemotherapy.
4/2001Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum.
1/2001Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m2 over 3 h) employed in the treatment of gynecologic malignancies.
10/2000Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer.
7/2000The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
5/2000Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia.
5/2000Declining CA-125 in an ovarian cancer patient with progression of measurable disease: a rational hypothesis for discordant results.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Kennedy Research Topics

Disease

11Neoplasms (Cancer)
01/2021 - 01/2000
10Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 05/2000
4Prostatic Neoplasms (Prostate Cancer)
01/2021 - 04/2001
4Inflammation (Inflammations)
07/2010 - 02/2005
3Neutropenia
04/2001 - 05/2000
3Carcinoma (Carcinomatosis)
04/2001 - 09/2000
2Infections
05/2019 - 05/2000
2Insulin Resistance
03/2012 - 05/2010
2Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2011 - 03/2005
2Necrosis
07/2010 - 02/2005
2Cognitive Dysfunction
01/2009 - 03/2005
2Alzheimer Disease (Alzheimer's Disease)
01/2009 - 02/2007
2Diabetic Retinopathy (Retinopathy, Diabetic)
09/2001 - 09/2001
2Fallopian Tube Neoplasms
04/2001 - 09/2000
2Hypersensitivity (Allergy)
04/2001 - 01/2000
2Fever (Fevers)
10/2000 - 05/2000
2Vomiting
08/2000 - 07/2000
1Opioid-Related Disorders (Opiate Addiction)
01/2020
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2018
1Pain (Aches)
12/2016
1Adenocarcinoma
04/2015
1Barrett Esophagus (Barrett's Esophagus)
04/2015
1Type 2 Diabetes Mellitus (MODY)
03/2012
1Diabetes Complications
03/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2011
1Arthritis (Polyarthritis)
07/2010
1Obesity
05/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2007
1Chronic Disease (Chronic Diseases)
08/2007
1Amyloid Plaque
02/2007
1Breast Neoplasms (Breast Cancer)
12/2006
1Acquired CJD
03/2005
1Ulcerative Colitis
02/2005
1Anorexia Nervosa
08/2004
1Weight Gain
08/2004
1Hodgkin Disease (Hodgkin's Disease)
02/2002
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2002
1Lymphoma (Lymphomas)
02/2002

Drug/Important Bio-Agent (IBA)

7Paclitaxel (Taxol)FDA LinkGeneric
10/2009 - 01/2000
5Carboplatin (JM8)FDA LinkGeneric
12/2001 - 07/2000
4PlatinumIBA
12/2001 - 09/2000
3CytokinesIBA
07/2010 - 02/2005
2Biomarkers (Surrogate Marker)IBA
10/2020 - 04/2015
2Anti-Bacterial Agents (Antibiotics)IBA
05/2019 - 05/2000
2Glucose (Dextrose)FDA LinkGeneric
03/2012 - 02/2007
2Oxygen (Dioxygen)IBA
07/2010 - 11/2000
2Amyloid (Amyloid Fibrils)IBA
01/2009 - 02/2007
2Antineoplastic Agents (Antineoplastics)IBA
09/2000 - 01/2000
1Biological ProductsIBA
07/2020
1Naloxone (Narcan)FDA LinkGeneric
01/2020
1AutoantibodiesIBA
01/2018
1LipidsIBA
03/2012
1Quinacrine (Mepacrine)IBA
11/2011
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2010
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
07/2010
1Interferon-gamma (Interferon, gamma)IBA
07/2010
1Interleukin-8 (Interleukin 8)IBA
07/2010
1Interleukin-6 (Interleukin 6)IBA
07/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010
1PowdersIBA
05/2010
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2010
1NF-kappa B (NF-kB)IBA
05/2010
1Conditioned Culture MediaIBA
05/2010
1PolyphenolsIBA
05/2010
1ChemokinesIBA
05/2010
1ProstaglandinsIBA
05/2010
1LipopolysaccharidesIBA
05/2010
1EmulsionsIBA
10/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2009
1perfluoropentane (perflenapent)IBA
10/2009
1Amyloid beta-PeptidesIBA
01/2009
1NucleophosminIBA
09/2007
1Protein Sorting Signals (Signal Peptide)IBA
12/2006
1Messenger RNA (mRNA)IBA
12/2006
1Proteins (Proteins, Gene)FDA Link
12/2006
1PrionsIBA
03/2005
1Prion ProteinsIBA
03/2005
1Interleukin-1alpha (Interleukin 1 alpha)IBA
02/2005
1DefensinsIBA
02/2005
1Ferritins (Ferritin)IBA
08/2004
1IronIBA
08/2004
1Rituximab (Mabthera)FDA Link
02/2002
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2002
1CA-125 Antigen (CA 125 Antigen)IBA
12/2001
1Tumor Biomarkers (Tumor Markers)IBA
12/2001
1AntioxidantsIBA
09/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2001

Therapy/Procedure

7Therapeutics
11/2011 - 05/2000
5Drug Therapy (Chemotherapy)
12/2001 - 05/2000
3Radiotherapy
01/2021 - 02/2002
2Combination Drug Therapy (Combination Chemotherapy)
04/2001 - 01/2001
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021
1Esophagectomy
04/2015
1Microbubbles
10/2009
1Ultrasonic Therapy
10/2009
1Continuity of Patient Care
08/2007
1Aftercare (After-Treatment)
02/2005
1Ovariectomy (Oophorectomy)
03/2002
1Consolidation Chemotherapy
02/2002
1Autologous Transplantation
02/2002